⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RPRX News
Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma to present at upcoming investor conferences
globenewswire.com
RPRX
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
globenewswire.com
RPRX
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
prnewswire.com
AMGN
CGON
CLNN
RPRX
BTAI
ONCY
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
globenewswire.com
RPRX
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
globenewswire.com
RPRX
Form 8-K
sec.gov
RPRX
Royalty Pharma reports second quarter 2026 results
globenewswire.com
RPRX
Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives
globenewswire.com
RPRX
Secretome Therapeutics Expands Rare Disease Leadership Team
businesswire.com
SRPT
RPRX
PFE
BIIB
GILD
AMGN
ATRA
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
globenewswire.com
RPRX